BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 37435466)

  • 1. Pheochromocytoma and paraganglioma: germline genetics and hereditary syndromes.
    Turin CG; Crenshaw MM; Fishbein L
    Endocr Oncol; 2022 Jan; 2(1):R65-R77. PubMed ID: 37435466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pheochromocytoma/Paraganglioma: Is This a Genetic Disorder?
    Fishbein L
    Curr Cardiol Rep; 2019 Jul; 21(9):104. PubMed ID: 31367972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas.
    Welander J; Söderkvist P; Gimm O
    Endocr Relat Cancer; 2011 Dec; 18(6):R253-76. PubMed ID: 22041710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of SDHB and FH immunohistochemistry in patients evaluated for hereditary paraganglioma-pheochromocytoma syndromes.
    Udager AM; Magers MJ; Goerke DM; Vinco ML; Siddiqui J; Cao X; Lucas DR; Myers JL; Chinnaiyan AM; McHugh JB; Giordano TJ; Else T; Mehra R
    Hum Pathol; 2018 Jan; 71():47-54. PubMed ID: 29079178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pheochromocytoma and Paraganglioma: From Epidemiology to Clinical Findings.
    Aygun N; Uludag M
    Sisli Etfal Hastan Tip Bul; 2020; 54(2):159-168. PubMed ID: 32617052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Clinicopathologic and Molecular Analysis of Fumarate Hydratase-deficient Pheochromocytoma and Paraganglioma.
    Fuchs TL; Luxford C; Clarkson A; Sheen A; Sioson L; Elston M; Croxson MS; Dwight T; Benn DE; Tacon L; Field M; Ahadi MS; Chou A; Clifton-Bligh RJ; Gill AJ
    Am J Surg Pathol; 2023 Jan; 47(1):25-36. PubMed ID: 35993574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia Pathway Mutations in Pheochromocytomas and Paragangliomas.
    Amorim-Pires D; Peixoto J; Lima J
    Cytogenet Genome Res; 2016; 150(3-4):227-241. PubMed ID: 28231563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paragangliomas: update on differential diagnostic considerations, composite tumors, and recent genetic developments.
    Papathomas TG; de Krijger RR; Tischler AS
    Semin Diagn Pathol; 2013 Aug; 30(3):207-23. PubMed ID: 24144290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pheochromocytoma and paraganglioma: implications of germline mutation investigation for treatment, screening, and surveillance.
    Gómez AM; Soares DC; Costa AAB; Pereira DP; Achatz MI; Formiga MN
    Arch Endocrinol Metab; 2019 Jul; 63(4):369-375. PubMed ID: 31365623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The genomic landscape of phaeochromocytoma.
    Flynn A; Benn D; Clifton-Bligh R; Robinson B; Trainer AH; James P; Hogg A; Waldeck K; George J; Li J; Fox SB; Gill AJ; McArthur G; Hicks RJ; Tothill RW
    J Pathol; 2015 May; 236(1):78-89. PubMed ID: 25545346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Management of Pheochromocytoma/Paraganglioma: A Guide for the Practicing Clinician in the Era of Precision Medicine.
    Nölting S; Ullrich M; Pietzsch J; Ziegler CG; Eisenhofer G; Grossman A; Pacak K
    Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31597347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background.
    Fishbein L; Nathanson KL
    Cancer Genet; 2012; 205(1-2):1-11. PubMed ID: 22429592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas.
    Castro-Vega LJ; Buffet A; De Cubas AA; Cascón A; Menara M; Khalifa E; Amar L; Azriel S; Bourdeau I; Chabre O; Currás-Freixes M; Franco-Vidal V; Guillaud-Bataille M; Simian C; Morin A; Letón R; Gómez-Graña A; Pollard PJ; Rustin P; Robledo M; Favier J; Gimenez-Roqueplo AP
    Hum Mol Genet; 2014 May; 23(9):2440-6. PubMed ID: 24334767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic testing in the clinical care of patients with pheochromocytoma and paraganglioma.
    Rana HQ; Rainville IR; Vaidya A
    Curr Opin Endocrinol Diabetes Obes; 2014 Jun; 21(3):166-76. PubMed ID: 24739310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma.
    Burnichon N; Cascón A; Schiavi F; Morales NP; Comino-Méndez I; Abermil N; Inglada-Pérez L; de Cubas AA; Amar L; Barontini M; de Quirós SB; Bertherat J; Bignon YJ; Blok MJ; Bobisse S; Borrego S; Castellano M; Chanson P; Chiara MD; Corssmit EP; Giacchè M; de Krijger RR; Ercolino T; Girerd X; Gómez-García EB; Gómez-Graña A; Guilhem I; Hes FJ; Honrado E; Korpershoek E; Lenders JW; Letón R; Mensenkamp AR; Merlo A; Mori L; Murat A; Pierre P; Plouin PF; Prodanov T; Quesada-Charneco M; Qin N; Rapizzi E; Raymond V; Reisch N; Roncador G; Ruiz-Ferrer M; Schillo F; Stegmann AP; Suarez C; Taschin E; Timmers HJ; Tops CM; Urioste M; Beuschlein F; Pacak K; Mannelli M; Dahia PL; Opocher G; Eisenhofer G; Gimenez-Roqueplo AP; Robledo M
    Clin Cancer Res; 2012 May; 18(10):2828-37. PubMed ID: 22452945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic status determines
    Tiwari A; Shah N; Sarathi V; Malhotra G; Bakshi G; Prakash G; Khadilkar K; Pandit R; Lila A; Bandgar T
    J Med Imaging Radiat Oncol; 2017 Dec; 61(6):745-752. PubMed ID: 28585398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathological mechanisms and parent-of-origin effects in hereditary paraganglioma/pheochromocytoma (PGL/PCC).
    Müller U
    Neurogenetics; 2011 Aug; 12(3):175-81. PubMed ID: 21547462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting pheochromocytoma/paraganglioma with polyamine inhibitors.
    Rai SK; Bril F; Hatch HM; Xu Y; Shelton L; Kalavalapalli S; Click A; Lee D; Beecher C; Kirby A; Kong K; Trevino J; Jha A; Jatav S; Kriti K; Luthra S; Garrett TJ; Guingab-Cagmat J; Plant D; Bose P; Cusi K; Hromas RA; Tischler AS; Powers JF; Gupta P; Bibb J; Beuschlein F; Robledo M; Calsina B; Timmers H; Taieb D; Kroiss M; Richter S; Langton K; Eisenhofer G; Bergeron R; Pacak K; Tevosian SG; Ghayee HK
    Metabolism; 2020 Sep; 110():154297. PubMed ID: 32562798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and genetic testing outcomes of patients with clinically suspected paraganglioma/pheochromocytoma (PGL/PCC) syndrome in Singapore.
    Ting KR; Ong PY; Wei SOG; Parameswaran R; Khoo CM; Deepak DS; Lee SC
    Hered Cancer Clin Pract; 2020 Dec; 18(1):24. PubMed ID: 33308260
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.